A Closer Look at FDA’s Newly Released AI/ML Action Plan
FDA’s new Action Plan takes steps toward establishing a dedicated regulatory strategy for AI products intended as software as a medical device.

FDA’s new Action Plan takes steps toward establishing a dedicated regulatory strategy for AI products intended as software as a medical device.
